Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,333 public trials 1,294 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Recruiting

Target of Suv420h1/2 in Hepatocytes

NCT06332677

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica Milan, Italy
View Trial Details
Recruiting

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

NCT07331883

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Sanming First Hospital Sanming, Fujian, China
  • The Third Bethune Hospital of Jilin University Changchun, Jilin, China
  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

NCT06273644

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Genetic Diseases, Inborn, +9 more
Locations
  • Nordland Hospital Trust Bodø, Nordland, Norway
  • Studieenheten, Akademiskt Specialistcentrum, Stockholm läns sjukvårdsområde, Region Stockholm Stockholm, Sweden
  • Norrland University Hospital Umeå, Sweden
View Trial Details
Recruiting

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

NCT05024214

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The Seventh Medical Center of the PLA General Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 23 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

NCT06858813

Conditions
Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +5 more
Locations
  • City of Hope National Medical Center /ID# 270526 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 276120 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 271573 Los Angeles, California, United States
  • UC Irvine Medical Center /ID# 270507 Orange, California, United States
View all 22 locations
View Trial Details

Related conditions